Literature DB >> 34126576

Incorporation of a FRET pair within a phosphonate diester.

Nyema M Harmon1, Xueting Huang2, Chia-Hung Christine Hsiao2, Andrew J Wiemer3, David F Wiemer4.   

Abstract

Cell-cleavable protecting groups are an effective tactic for construction of biological probes because such compounds can improve problems with instability, solubility, and cellular uptake. Incorporation of fluorescent groups in the protecting groups may afford useful probes of cellular functions, especially for payloads containing phosphonates that would be highly charged if not protected, but little is known about the steric or electronic factors that impede release of the payload. In this report we present a strategy for the synthesis of a coumarin fluorophore and a 4-((4-(dimethylamino)phenyl)diazenyl)benzoic acid (DABCYL) ester chromophore incorporated as a FRET pair within a single phosphonate. Such compounds were designed to deliver a BTN3A1 ligand payload to its intracellular receptor. Both final products and some synthetic intermediates were evaluated for their ability to undergo metabolic activation in γδ T cell functional assays, and for their photophysical properties by spectrophotometry. One phosphonate bearing a DABCYL acyloxyester and a novel tyramine-linked coumarin fluorophore exhibited strong, rapid, and potent cellular activity for γδ T cell stimulation and also showed FRET interactions. This strategy demonstrates that bioactivatable phosphonates containing FRET pairs can be utilized to develop probes to monitor cellular uptake of otherwise charged payloads.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BTN3A1; Dark quencher; FRET; Forster resonance energy transfer; Phosphoantigen; Prodrug

Mesh:

Substances:

Year:  2021        PMID: 34126576      PMCID: PMC8387413          DOI: 10.1016/j.bioorg.2021.105048

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.307


  34 in total

Review 1.  Phosphonate prodrugs: an overview and recent advances.

Authors:  Kenneth M Heidel; Cynthia S Dowd
Journal:  Future Med Chem       Date:  2019-07       Impact factor: 3.808

2.  Opportunities and challenges in development of phosphoantigens as Vγ9Vδ2 T cell agonists.

Authors:  David F Wiemer; Andrew J Wiemer
Journal:  Biochem Pharmacol       Date:  2014-03-26       Impact factor: 5.858

3.  Revising Intramolecular Photoinduced Electron Transfer (PET) from First-Principles.

Authors:  Daniel Escudero
Journal:  Acc Chem Res       Date:  2016-08-30       Impact factor: 22.384

4.  Selective chemical catalysis by an antibody.

Authors:  S J Pollack; J W Jacobs; P G Schultz
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

5.  A novel selective broad-spectrum anti-DNA virus agent.

Authors:  E De Clercq; A Holý; I Rosenberg; T Sakuma; J Balzarini; P C Maudgal
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

Review 6.  Förster resonance energy transfer (FRET) and applications thereof.

Authors:  Amrita Kaur; Pardeep Kaur; Sahil Ahuja
Journal:  Anal Methods       Date:  2020-12-07       Impact factor: 2.896

Review 7.  Förster resonance energy transfer (FRET)-based small-molecule sensors and imaging agents.

Authors:  Luling Wu; Chusen Huang; Ben P Emery; Adam C Sedgwick; Steven D Bull; Xiao-Peng He; He Tian; Juyoung Yoon; Jonathan L Sessler; Tony D James
Journal:  Chem Soc Rev       Date:  2020-07-22       Impact factor: 54.564

Review 8.  Enhancement of Curcumin Bioavailability Via the Prodrug Approach: Challenges and Prospects.

Authors:  Pahweenvaj Ratnatilaka Na Bhuket; Asma El-Magboub; Ian S Haworth; Pornchai Rojsitthisak
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

9.  Investigation of enzyme activity by SERRS using poly-functionalised benzotriazole derivatives as enzyme substrates.

Authors:  Andrew M Ingram; Kirsten Stirling; Karen Faulds; Barry D Moore; Duncan Graham
Journal:  Org Biomol Chem       Date:  2006-07-03       Impact factor: 3.876

10.  Potent double prodrug forms of synthetic phosphoantigens.

Authors:  Nyema M Harmon; Xueting Huang; Megan A Schladetsch; Chia-Hung Christine Hsiao; Andrew J Wiemer; David F Wiemer
Journal:  Bioorg Med Chem       Date:  2020-07-29       Impact factor: 3.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.